Inherited thrombophilia: Resistance to activated protein C as a pathogenic factor of venous thromboembolism

Blood

Volumn 85, Issue 3, 1995, Pages 607-614

  Dahlbäck, Björn ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT PROTEIN; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; PROTEIN C; PROTEIN S; THROMBOMODULIN;

ANTICOAGULATION; FAMILY HISTORY; GENE MUTATION; GENETIC LINKAGE; HUMAN; INHERITANCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 0028959158     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v85.3.607.bloodjournal853607     Document Type: Review

References (93)

1. Goldhaber SZ: Epidemiology of pulmonary embolism and deep vein thrombosis, in Bloom AL, Forbes CD, Thomas DP, Tuddenhamm EGD (eds): Haemostasis and Thrombosis. Edinburgh, UK, Churchill Livinstone, 1994, p 1327
2. Thomas DP: Pathogenesis of venous thrombosis, in Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (eds): Haemostasis and Thrombosis. Edinburgh, UK, Churchill Livingstone, 1994, p 1335
3. Allaart CF, Briët E: Familial venous thrombophilia, in Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (eds): Haemostasis and Thrombosis. Edinburgh, UK, Churchill Livingstone, 1994, p 1349
4. Malm J, Laurell M, Nilsson IM, Dahlbäck B: Thromboembolic disease - Critical evaluation of laboratory investigation. Thromb Haemost 68:7, 1992
5. Heijboer H, Brandjes D, Büller HR, Sturk A, ten Cate JW: Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 323:1512, 1990
6. Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG: Inherited predisposion to thrombosis. Cell 72:477, 1993
7. Tabernero MD, Tomas JF, Alberca I, Orfao A, Borrasca AL, Vicente V: Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis. Am J Hematol 36:249, 1991
8. Dahlbäck B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004, 1993
9. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64, 1994
10. Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B: Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 343:1362, 1994
11. Zöller B, Dahlbäck B: Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 343:1536, 1994
12. Voorberg J, Roelse J, Koopman R, Büller H, Berends F, ten Cate JW, Mertens K, van Mourik JA: Association of idiopathic thromboembolism with single point mutation at Arg506 of factor V. Lancet 343:1535, 1994
13. Sun X, Evatt B, Griffin JH: Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood 83:3120, 1994
14. Svensson PJ, Dahlbäck B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517, 1994
15. Koster T, Rosendaal FR, de Ronde F, Briët E, Vandenbroucke JP, Bertina RM: Venous thrombosis due to poor response to activated protein C: Leiden thrombophilia study. Lancet 342:1503, 1993
16. Bauer KA, Rosenberg RD: Role of antithrombin III as a regulator of in vivo coagulation. Semin Hematol 28:10, 1991
17. Broze GJ Jr, Tollefsen DM: Regulation of blood coagulation by protease inhibitors, in Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H (eds): The Molecular Basis of Blood Diseases. Philadelphia, PA, Saunders, 1994, p 629
18. Lane DA, Olds RR, Thein SL: Antithrombin and its deficiency states. Blood Coagul Fibrinol 3:315, 1992
19. Davie EW, Fujikawa K, Kisiel W: The coagulation cascade: Initiation, maintainance, and regulation. Biochemistry 30:10363, 1991
20. Nemerson Y: Tissue factor and hemostasis. Blood 71:1, 1988
21. Furie B. Furie BC: The molecular basis of blood coagulation. Cell 53:505, 1988
22. Kane WH, Davie EW: Blood coagulation factors V and VIII: Structural and functional similarities and their relationship to hemorrhagic and trombotic disorders. Blood 71:539, 1988
23. Jenny RJ, Tracy PB, Mann KG: The physiology and biochemistry of factor V, in Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (eds): Haemostasis and Thrombosis. Edinburgh, UK, Churchill Livingstone, 1994, p 465
24. Esmon CT: Molecular events that control the protein C anticoagulant pathway. Thromb Haemost 70:29, 1993
25. Esmon CT: Cell mediated events that control blood coagulation and vascular injury. Annu Rev Cell Biol 9:1, 1993
26. Dahlbäck B: Protein S and C4b-binding protein: Components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 66:49, 1991
27. Esmon CT: The protein C anticoagulant pathway. Arterioscler Thromb 12:135, 1992
28. Dahlbäck B, Stenflo J: The protein C anticoagulant system, in Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H (eds): The Molecular Basis of Blood Diseases. Philadelphia, PA. Saunders, 1994, p 599
29. Walker FJ, Fay PJ: Regulation of blood coagulation by the protein C system. FASEB J 6:2561, 1992
30. Shen L, Dahlbäck B: Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem 269:18735, 1994
31. Marlar RA, Kressin DC, Madden RM: Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma. Thromb Haemost 69:16, 1993
32. Fay PJ: Factor VIII structure and function. Thromb Haemost 70:63, 1993
33. Kalifatis M, Mann KG: Role of the membrane in the inactivation of factor Va by activated protein C. J Biol Chem 268:27246, 1993
34. Odegaard B, Mann KG: Proteolysis of factor Va by factor Xa and activated protein C. J Biol Chem 262:11233, 1987
35. Esmon CT: The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264:4743, 1989
36. Stenflo J: A new vitamin K-dependent protein. J Biol Chem 251:355, 1976
37. Kisiel W. Canfield WM, Ericsson LH, Davie EW: Anticoagulant properties of bovine plasma protein C following activation by thrombin. J Biol Chem 16:5824, 1977
38. Esmon CT, Owen WG: Identification of an endothelial cell cofactor for thrombin catalyzed activation of protein C. Proc Natl Acad Sci USA 78:2249, 1981
39. Esmon NL, Owen WG, Esmon CT: Isolation of a membranebound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 257:859, 1982
40. Dahlbäck B, Lundwall A, Stenflo J: Primary structure of bovine vitamin K-dependent protein S. Proc Natl Acad Sci USA 83:4199, 1986
41. Discipio RG, Hermodson MA, Yates SG, Davie EW: A comparison of human prothrombin, factor IX, factor X, and protein S. Biochemistry 16:698, 1977
42. Walker FJ: Regulation of activated protein C by a new protein. J Biol Chem 255:5521, 1980
43. Walker FJ: Regulation of activated protein C by protein S, the role of phospholipid in factor Va inactivation. J Biol Chem 256:11128, 1981
44. Dahlbäck B, Stenflo J: High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci USA 78:2512, 1981
45. Dahlbäck B: Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin. Biochem J 209:837, 1983
46. Dahlbäck B: Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem J 209:847, 1983
47. a cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 261:12022, 1986
48. Bertina RM, van Wijngaarden A, Reinalda-Poot J, Poort SR, Bom VJ: Determination of plasma protein S - The protein cofactor of activated protein C. Thromb Haemost 53:268, 1985
49. Comp PC, Nixon RR, Cooper MR, Esmon CT: Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 74:2082, 1984
50. Nelsestuen GL, Kisiel W, Discipio RG: Interaction of vitamin K dependent proteins with membranes. Biochemistry 17:2134, 1978
51. Suzuki K, Nishioka J, Matsuda J, Maruyama I, Hashimoto S: Protein S is essential for the activated protein C-catalyzed inactivation of platelet-associated factor Va. J Biochem 96:455, 1984
52. Harris KW, Esmon CT: Protein S is required for bovine platelets to support activated protein C binding and activity. J Biol Chem 260:2007, 1985
53. Stern DM, Nawroth PP, Harris KW, Esmon CT: Cultured bovine aortic endothelial cells promote activated protein C-protein S-mediated inactivation of factor Va. J Biol Chem 261:713, 1986
54. Dahlbäck B, Wiedmer T, Sims PJ: Binding of anticoagulant vitamin K-dependent protein S to platelet-derived microparticles. Biochemistry 31:12769, 1992
55. Bakker H, Tans G, Janssen-Claessen T, Thomassen MCLGD, Hemker HC, Griffin JH, Rosing J: The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C. Eur J Biochem 208:171, 1992
56. Solymoss S, Tucker MM, Tracy PB: Kinetics of inactivation of membrane-bound factor V by activated protein C. J Biol Chem 263:14884, 1988
57. 562. J Biol Chem 269:9445, 1994
58. Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH: Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 268:2872, 1993
59. Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin JH: Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci USA 91:2728, 1994
60. Salem HH, Esmon NL, Esmon CT, Majerus PW: Effects of thrombomodulin and coagulation factor Va-light chain on protein C activation in vitro. J Clin Invest 73:968, 1984
61. Gladson CL, Scharrer I, Hach V, Beck KH, Griffin JH, The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 59:18, 1988
62. Bovill EG, Bauer KA, Dickermann JD, Callas P, West B: The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 73:712, 1989
63. Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briët E: Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 341:134, 1993
64. Reitsma PH, Poort SR, Allaart CF, Briët E, Bertina RM: The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: Heterogeneity and founder effects. Blood 78:890, 1991
65. Miletich JP, Sherman L, Broze GJ Jr: Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 317:991, 1987
66. Seligsohn U, Berger A, Abend A, Rubin L, Attias D, Zivelin A, Rapaport SI: Homozygous protein C deficiency manifested by massive thrombosis in the newborn. N Engl J Med 310:559, 1984
67. Reitsma PH, Poort SR, Bernardi F, Gandrille S, Long GL, Sala N, Cooper DN: Protein C deficiency: A database of mutations. Thromb Haemost 69:77, 1993
68. Marlar RA, Neumann A: Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies. Semin Thromb Hemost 16:299, 1990
69. Dreyfus M, Magny JF, Bridey F, Schwarz HP, Planché C, Dehan M, Tchernia G: Treatment of homozygous protein C deficiency and neonatal purpura fulminans with purified protein C concentrate. N Engl J Med 325:1565, 1991
70. Engesser L, Broekmans AW. Briët E, Brommer EJP, Bertina RM: Hereditary protein S deficiency: Clinical manifestations. Ann Intern Med 106:677, 1987
71. Mannucci PM, Tripodi A, Bertina RM: Protein S deficiency associated with "juvenile" arterial and venous thrombosis. Thromb Haemost 55:440, 1986
72. Allaart CF, Aronson DC, Ruys T, Rosendaal FR, van Bockel JH, Bertina RM, Briët E: Hereditary protein S deficiency in young adults with arterial occlusive disease. Thromb Haemost 64:206, 1990
73. Comp PC, Doray D, Patton D, Esmon CT: An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 67:504, 1986
74. Comp PC, Esmon CT: Recurrent thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 311:1525, 1984
75. Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH: Plasma protein S deficiency in familial thrombotic disease. Blood 64:1297, 1984
76. Mannucci PM, Valsecchi C, Krashmalnicoft A, Faioni EM, Tripodi A: Familial dysfunction of protein S. Thromb Haemost 62:763, 1989
77. Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzuki K: Protein S Tokushima: Abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. Blood 83:683, 1994
78. Faioni EM, Franchi F, Asti D, Sacchi E, Bernardi F, Mannucci PM: Resistance to activated protein C in nine thrombophilic families: Interference in a protein S functional assay. Thromb Haemost 70:1067, 1993
79. Reitsma PH, Ploos van Amstel HK, Bertina RM: Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I. J Clin Invest 93:486, 1994
80. Schmidel DK, Nelson RM, Broxson EH, Comp PC, Marlar RA, Long GL: A 5.3-kb deletion including exon XIII of the protein S a gene occurs in two protein S-deficient families. Blood 77:551, 1991
81. Ploos van Amstel HK, Huisman MV, Reitsma PH, ten Cate JW, Bertina RM: Partial protein S gene deletion in a family with hereditary thrombophilia. Blood 73:479, 1989
82. Bertina RM, Ploos van Amstel HK, van Wijngaarden A, Coenen J, Leemhuis MP, Deutz-Terlouw PP, Van Der Linden IK, Reitsma PH: Heerlen polymorphism of the protein S, an immunologic polymorphism due to dimorphism of residue 460. Blood 76:538, 1990
83. Dahlbäck B, Hildebrand B: Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 81:1396, 1994
84. Hellgren M, Svensson PJ, Dahlbäck B: Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gyn 1994 (in revision)
85. Zöller B, Svensson PJ, He X, Dahlbäck B: Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 94:2521, 1994
86. Griffin JH, Evatt B, Wideman C, Fernandez JA: Anticoagulant protein C pathway defective in a majority of thrombophilic patients. Blood 82:1989, 1993
87. Halbmayer WM, Haushofer A, Schön R, Fischer M: The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coagul Fibrinol 5:51, 1994
88. Cadroy Y, Sié P, Boneu B: Frequency of a defective response to activated protein C in patients with a history of venous thrombosis. Blood 83:2008, 1994
89. Lindblad B, Svensson PJ, Dahlbäck B: Arterial and venous thromboembolism with fatal outcome in a young man with inherited resistance to activated protein C. Lancet 343:917, 1994
90. Holm J, Zöller B, Svensson PJ, Berntorp E, Erhardt L, Dahlbäck B: Myocardial infarction in two young women associated with homozygous resistance to activated protein C. Lancet 344:952, 1994
91. Majerus PW: Bad blood by mutation. Nature 369:14, 1994
92. Bauer KA: Hypercoagulability - A new cofactor in the protein C anticoagulant pathway. N Engl J Med 330:566, 1994
93. Dahlbäck B: Bovine coagulation factor V visualized with electron microscopy; ultrastructure of the isolated activated forms and of the activation fragments. J Biol Chem 261:9495, 1986